Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Brugia malayi | hypothetical protein | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Echinococcus multilocularis | survival motor neuron protein 1 | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Echinococcus granulosus | survival motor neuron protein 1 | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | amidase | 0.0041 | 0.088 | 0.5 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0208 | 0.0208 |
Wolbachia endosymbiont of Brugia malayi | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0041 | 0.088 | 0.5 |
Plasmodium vivax | glutamyl-tRNA(Gln) amidotransferase subunit A, putative | 0.0041 | 0.088 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0041 | 0.088 | 0.088 |
Brugia malayi | hypothetical protein | 0.0286 | 0.8298 | 0.8298 |
Trypanosoma cruzi | amidase, putative | 0.0041 | 0.088 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1457 | 0.1457 |
Mycobacterium tuberculosis | Possible amidase (aminohydrolase) | 0.0041 | 0.088 | 0.5 |
Mycobacterium ulcerans | amidase | 0.0041 | 0.088 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1457 | 0.1457 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0208 | 0.0208 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0208 | 0.0208 |
Echinococcus granulosus | glutamyl tRNAGln amidotransferase subunit A | 0.0041 | 0.088 | 0.088 |
Leishmania major | hypothetical protein, conserved | 0.0041 | 0.088 | 0.5 |
Mycobacterium ulcerans | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0041 | 0.088 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0208 | 0.0208 |
Brugia malayi | Amidase family protein | 0.0041 | 0.088 | 0.088 |
Trypanosoma cruzi | amidase, putative | 0.0041 | 0.088 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0879 | 0.0879 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0208 | 0.0208 |
Mycobacterium leprae | PROBABLE AMIDASE AMIC (AMINOHYDROLASE) | 0.0041 | 0.088 | 0.5 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0041 | 0.088 | 0.088 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0208 | 0.0208 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.8298 | 0.8298 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1457 | 0.1457 |
Mycobacterium ulcerans | peptide amidase, GatA | 0.0041 | 0.088 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.4006 | 0.4006 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0879 | 0.0879 |
Echinococcus multilocularis | glutamyl tRNA(Gln) amidotransferase subunit A | 0.0041 | 0.088 | 0.088 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0208 | 0.0208 |
Mycobacterium tuberculosis | Probable amidase AmiA2 (aminohydrolase) | 0.0041 | 0.088 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0208 | 0.0208 |
Trypanosoma brucei | fatty-acid amide hydrolase, putative | 0.0041 | 0.088 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.4006 | 0.4006 |
Mycobacterium tuberculosis | Probable amidase AmiD (acylamidase) (acylase) | 0.0041 | 0.088 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.8298 | 0.8298 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0208 | 0.0208 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.1398 | 0.1398 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.1398 | 0.1398 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0208 | 0.0208 |
Mycobacterium tuberculosis | Probable amidase AmiC (aminohydrolase) | 0.0041 | 0.088 | 0.5 |
Mycobacterium ulcerans | amidase | 0.0041 | 0.088 | 0.5 |
Loa Loa (eye worm) | amidase | 0.0041 | 0.088 | 0.088 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0041 | 0.088 | 0.088 |
Mycobacterium ulcerans | amidase | 0.0041 | 0.088 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0879 | 0.0879 |
Mycobacterium tuberculosis | Probable amidase AmiB2 (aminohydrolase) | 0.0041 | 0.088 | 0.5 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.1398 | 0.1398 |
Treponema pallidum | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0041 | 0.088 | 0.5 |
Mycobacterium leprae | PROBABLE GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE (SUBUNIT A) GATA (Glu-ADT SUBUNIT A) | 0.0041 | 0.088 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.4006 | 0.4006 |
Plasmodium falciparum | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0041 | 0.088 | 0.5 |
Mycobacterium ulcerans | amidase | 0.0041 | 0.088 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0208 | 0.0208 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0208 | 0.0208 |
Schistosoma mansoni | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0041 | 0.088 | 0.088 |
Chlamydia trachomatis | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0041 | 0.088 | 0.5 |
Onchocerca volvulus | 0.0058 | 0.1398 | 1 | |
Brugia malayi | Amidase family protein | 0.0041 | 0.088 | 0.088 |
Loa Loa (eye worm) | amidase | 0.0041 | 0.088 | 0.088 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1457 | 0.1457 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.8298 | 0.8298 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0208 | 0.0208 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0208 | 0.0208 |
Brugia malayi | putative amidase | 0.0041 | 0.088 | 0.088 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.3323 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 2.8184 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.0119 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 7.9433 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.